Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial-Reference-Cited by-同舟云学术

Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial

Published:2017-02 Issue:2 Volume:39 Page:268-278.e2
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Shin Kichul,Park Sung-Hwan,Park Won,Baek Han Joo,Lee Yun Jong,Kang Seong Wook,Choe Jung-Yoon,Yoo Wan-Hee,Park Yong-Beom,Song Jung-Soo,Lee Seung-Geun,Yoo Bin,Yoo Dae-Hyun,Song Yeong Wook

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis;Hauser;Rheumatology (Oxford),2014

2. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature;Fleurence;Pharmacoeconomics,2007

3. High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial;Hoes;Clin Exp Rheumatol,2010

4. 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis;Briot;Joint Bone Spine,2014

5. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis;Adachi;N Engl J Med,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis;PAIN, JOINTS, SPINE;2024-09-08

2. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study;HEALTH TECHNOL ASSES;2024

3. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?;Endocrine Reviews;2023-05-30

4. Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy;Reumatología Clínica;2023-05

5. Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy;Reumatología Clínica (English Edition);2023-05